Brand Logo

Healthy Lifestyle Combined With GLP-1 RA Use Lowers Cardiovascular Risk in Patients With Type 2 Diabetes

Findings to be presented at the American Heart Association Scientific Sessions 2025 in New Orleans suggest that combining healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) therapy can significantly lower cardiovascular risk in patients with type 2 diabetes (T2D). The data, presented in Abstract Poster MP511, highlight the additive benefits of lifestyle modification and…

Read More
Healthy lifestyle habits plus GLP-1 RA drugs can improve heart health of people with Type 2 diabetes

Healthy lifestyle habits plus GLP-1 RA drugs can improve heart health of people with Type 2 diabetes

People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including heart attack, stroke or cardiovascular disease death, compared to people only taking the medication, according to a preliminary study to be presented at the American Heart Association’s Scientific Sessions…

Read More